Adenylosuccinic acid

Names

[ CAS No. ]:
19046-78-7

[ Name ]:
Adenylosuccinic acid

[Synonym ]:
ADENYLOSUCCINIC ACID
N(6)-(1,2-dicarboxyethyl)-AMP
Aspartyl-AMP
adenylosuccnic acid
L-Aspartic acid 4-(5'-adenylyl) ester
Adenylobernsteinsaeure(L-)
Adenylsuccinic acid
aspartyl adenylate
N6-(1,2-dicarboxy-ethyl)-[5']adenylic acid
adenylosuccinic acid free acid

Biological Activity

[Description]:

Adenylosuccinic acid (Adenylosuccinate; Aspartyl adenylate) is a purine ribonucleoside monophosphate and plays a role in nucleotide cycle metabolite. Adenylosuccinic acid can be converted into fumaric acid through adenylosuccinate lyase. Adenylosuccinic acid has the potential for the study of duchenne muscular dystrophy(DMD)[1].

[Related Catalog]:

Research Areas >> Metabolic Disease

[Target]

IC50: ribonucleoside monophosphate[1]

[In Vivo]

Adenylosuccinic acid (oral administration; 3-3000 µg/mL; 6 weeks) significantly improves the features of murine DMD, it decreases the number of centronucleated fibres, lipid accumulation, connective tissue infiltration and Ca2+ content of mdx tibialis anterior[1]. Animal Model: C57Bl/10ScSn (normal wild-type strain; Con) and C57Bl/10mdx (mdx) mice[1] Dosage: 3 µg/mL, 30 µg/mL, 300 µg/mL, 3000 µg/mL Administration: 3 µg/mL for 3 days and 30 µg/mL for the next 4 days, and 300 µg/mL for one week, and then 3000 µg/mL for 6 weeks Result: Ameliorated the symptoms of murine duchenne muscular dystrophy.

[References]

[1]. Timpani CA, et al. Adenylosuccinic acid therapy ameliorates murine Duchenne Muscular Dystrophy.Sci Rep. 2020 Jan 24;10(1):1125.

Chemical & Physical Properties

[ Density]:
2.19g/cm3

[ Boiling Point ]:
921.9ºC at 760mmHg

[ Molecular Formula ]:
C₁₄H₁₈N₅O₁₁P

[ Molecular Weight ]:
463.29300

[ Flash Point ]:
511.3ºC

[ Exact Mass ]:
463.07400

[ PSA ]:
256.49000

[ Vapour Pressure ]:
0mmHg at 25°C

[ Index of Refraction ]:
1.833

MSDS

Click to get detail MSDS

Safety Information

[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
3

Synthetic Route

Click to get detail synthetic route

Precursor & DownStream

Precursor

DownStream

Articles

The RimL transacetylase provides resistance to translation inhibitor microcin C.

J. Bacteriol. 196(19) , 3377-85, (2014)

Peptide-nucleotide antibiotic microcin C (McC) is produced by some Escherichia coli strains. Inside a sensitive cell, McC is processed, releasing a nonhydrolyzable analog of aspartyl-adenylate, which ...

Synthesis and aminoacyl-tRNA synthetase inhibitory activity of aspartyl adenylate analogs.

Bioorg. Med. Chem. 13(1) , 69-75, (2005)

Three nonhydrolyzable aspartyl adenylate analogs have been prepared and tested as inhibitors of E. coli aspartyl-tRNA synthetase. 5'-O-[N-(L-Aspartyl)sulfamoyl]adenosine is a potent competitive inhibi...

MccE provides resistance to protein synthesis inhibitor microcin C by acetylating the processed form of the antibiotic.

J. Biol. Chem. 285(17) , 12662-9, (2010)

The heptapeptide-nucleotide microcin C (McC) is a potent inhibitor of enteric bacteria growth. McC is excreted from producing cells by the MccC transporter. The residual McC that remains in the produc...

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.